p53 status of head and neck cancer: relation to biological characteristics and outcome of radiotherapy
Open Access
- 1 June 1995
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 71 (6) , 1248-1252
- https://doi.org/10.1038/bjc.1995.241
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The Role of the p53 Tumor Suppressor Gene in Squamous Cell Carcinoma of the Head and NeckJAMA Otolaryngology–Head & Neck Surgery, 1993
- Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage.1993
- Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors.1993
- p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines.1993
- Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neckBritish Journal of Cancer, 1992
- Participation of p53 protein in the cellular response to DNA damage.1991
- Experience with CHARTInternational Journal of Radiation Oncology*Biology*Physics, 1991
- p53 Mutations in Human CancersScience, 1991
- Assessment of Human Tumour Proliferation Using Bromodeoxyuridine—Current StatusActa Oncologica, 1991
- UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells.Molecular and Cellular Biology, 1984